IP Library Granted Patent US 11,279,738
Granted Patent B2
US 11,279,738 · App. 16/946,333 · Granted Mar 22, 2022

Treatment of ischemia

Inventors: Roger P. Simon (Atlanta, GA); Zhigang Xiong (Atlanta, GA)
Assignee: MOREHOUSE SCHOOL OF MEDICINE
C07K14/43518A61K31/439A61K31/4418A61K31/498A61K31/4965A61K38/16A61K38/17A61K38/1767A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,279,738
App. No.
16/946,333
Granted
Mar 22, 2022
Kind
B2
Abstract

A system, including methods and compositions, for treatment of ischemia.

Claims (8)

1. A method of treating ischemia, comprising:

administering a therapeutically effective amount of a cystine knot peptide to an ischemic subject in order to reduce injury resulting from ischemia,

wherein the ischemia is caused by thrombosis, an embolism, atherosclerosis, hypertension, hemorrhage, an aneurysm, surgery, trauma, or medication, or wherein the ischemia is an ischemia-induced injury selected from the group consisting of ischemic myelopathy, ischemic optic neuropathy, ischemic colitis, coronary heart disease, cardiac heart disease, and stroke, and

wherein the cysteine knot peptide has an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5.

2. The method of claim 1 , wherein the cysteine knot peptide is administered to a subject that has suffered a stroke.

3. The method of claim 1 , wherein the step of administering includes a step of administering the inhibitor nasally, intrathecally, and/or epidurally.

4. The method of claim 1 , wherein the step of administering is performed less than about one day, twelve hours, or six hours prior to initiation of treatment.

5. The method of claim 1 , wherein the ischemia is stroke and wherein the step of administering is performed less than about one day, twelve hours, or six hours prior to initiation of treatment.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2022
From: SIMON, ROGER P.; XIONG, ZHIGANG
To: MOREHOUSE SCHOOL OF MEDICINE
Reel/Frame 058979/0907 →
Continuity (5)
Continuation 16391774 · Apr 23, 2019
Continuation 15638655 · Jun 30, 2017
Continuation 13284166 · Oct 28, 2011
Continuation 11724859 · Mar 16, 2007
Related Publication 20200354415A1 · Nov 12, 2020